Better Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
BTTX on Nasdaq
Location
548 Market St. #49404, San Francisco, California

Insiders trading volume in the past year

Better Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Perry Executive Chairman, Director, 10%+ Owner $3.7 M +$900 K +32.2% Feb 9, 2024
Georgianna Maule-Ffinch 2015 Trust 10%+ Owner $618 K Apr 10, 2023
Kevin J. Appelbaum Chief Executive Officer, Director, 10%+ Owner $410 K Mar 31, 2022
Geoffrey M. Parker Director $184 K +$500 K Dec 18, 2023
Andrew J. Armanino Director $127 K +$200 K Dec 18, 2023
Frank Karbe Chief Executive Officer, Director $89.5 K +$100 K Dec 18, 2023
Mark A. Berman Chief Medical Officer $76.1 K +$40 K +111% Dec 18, 2023
Kristin Wynholds Chief Product Officer $38.3 K Dec 18, 2023
Richard H. Carmona Director $26.7 K Dec 18, 2023
Mark Heinen Chief Financial Officer $24.1 K Mar 1, 2023
Elder Granger Director $6.73 K +$25 K Dec 18, 2023
Justin Zamirowski Chief Commercial Officer $6.27 K May 27, 2022
Leslie Miller Principal Accounting Officer $3.05 K Dec 18, 2023
Risa Lavizzo Mourey Director $2.34 K Dec 18, 2023
Suying Liu Director Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for Better Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership